154 related articles for article (PubMed ID: 36977229)
1. Histopathological Grading, Clinical Staging and CD 31 Expression of Canine Splenic Hemangiosarcoma.
Chu KT; Nekouei O; Sandy JR
Vet Sci; 2023 Mar; 10(3):. PubMed ID: 36977229
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of clinical and histologic factors associated with survival time in dogs with stage II splenic hemangiosarcoma treated by splenectomy and adjuvant chemotherapy: 30 cases (2011-2014).
Moore AS; Rassnick KM; Frimberger AE
J Am Vet Med Assoc; 2017 Sep; 251(5):559-565. PubMed ID: 28828962
[TBL] [Abstract][Full Text] [Related]
3. Claudin-5 protein is a new differential marker for histopathological differential diagnosis of canine hemangiosarcoma.
Jakab C; Halász J; Kiss A; Schaff Z; Rusvai M; Gálfi P; Abonyi TZ; Kulka J
Histol Histopathol; 2009 Jul; 24(7):801-13. PubMed ID: 19475526
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of Ki-67 in canine splenic hemangiosarcoma: A preliminary study.
Brigandì E; Valenti P; Bacci B; Brunetti B; Avallone G
Vet Pathol; 2024 Jan; ():3009858231225507. PubMed ID: 38214328
[TBL] [Abstract][Full Text] [Related]
5. A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.
Grimes JA; Prasad N; Levy S; Cattley R; Lindley S; Boothe HW; Henderson RA; Smith BF
BMC Vet Res; 2016 Dec; 12(1):272. PubMed ID: 27912752
[TBL] [Abstract][Full Text] [Related]
6. Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomy.
Faroni E; Sabattini S; Guerra D; Iannuzzi C; Chalfon C; Agnoli C; Stefanello D; Polton G; Ramos S; Aralla M; Ciaccini R; Foglia A; Okonji S; Marconato L
Vet Comp Oncol; 2023 Mar; 21(1):123-130. PubMed ID: 36633399
[TBL] [Abstract][Full Text] [Related]
7. [Adjuvant treatment of canine splenic hemangiosarcoma with autologous dendritic cell therapy - a prospective, randomized double-blind study].
Reck A; Gedon J; Kessler M
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2023 Dec; 51(6):394-402. PubMed ID: 38056478
[TBL] [Abstract][Full Text] [Related]
8. Development of perioperative premature ventricular contractions as an indicator of splenic hemangiosarcoma and median survival times.
Panissidi AA; DeSandre-Robinson DM
Vet Surg; 2021 Nov; 50(8):1609-1616. PubMed ID: 34351008
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of 43 small breed dogs treated for splenic hemangiosarcoma.
Story AL; Wavreille V; Abrams B; Egan A; Cray M; Selmic LE
Vet Surg; 2020 Aug; 49(6):1154-1163. PubMed ID: 32562436
[TBL] [Abstract][Full Text] [Related]
10. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012).
Wendelburg KM; Price LL; Burgess KE; Lyons JA; Lew FH; Berg J
J Am Vet Med Assoc; 2015 Aug; 247(4):393-403. PubMed ID: 26225611
[TBL] [Abstract][Full Text] [Related]
11. Identification of serum microRNAs with differential expression between dogs with splenic masses and healthy dogs with histologically normal spleens.
Grimes JA; Robinson KR; Bullington AM; Schmiedt JM
Am J Vet Res; 2021 Aug; 82(8):659-666. PubMed ID: 34296940
[TBL] [Abstract][Full Text] [Related]
12. Association of canine splenic hemangiosarcomas and hematomas with nodular lymphoid hyperplasia or siderotic nodules.
Cole PA
J Vet Diagn Invest; 2012 Jul; 24(4):759-62. PubMed ID: 22621950
[TBL] [Abstract][Full Text] [Related]
13. Canine splenic hemangiosarcoma cells express and activate luteinizing hormone receptors in vitro.
Zwida KH; Kutzler MA
Am J Vet Res; 2022 Nov; 83(12):. PubMed ID: 36327166
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hemangiosarcoma in anemic dogs with a splenic mass and hemoperitoneum requiring a transfusion: 71 cases (2003-2005).
Hammond TN; Pesillo-Crosby SA
J Am Vet Med Assoc; 2008 Feb; 232(4):553-8. PubMed ID: 18279091
[TBL] [Abstract][Full Text] [Related]
15. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
[TBL] [Abstract][Full Text] [Related]
16. Refining the "double two-thirds" rule: Genotype-based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogs.
Davies O; Taylor AJ
Vet Comp Oncol; 2020 Dec; 18(4):548-558. PubMed ID: 32043696
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985).
Prymak C; McKee LJ; Goldschmidt MH; Glickman LT
J Am Vet Med Assoc; 1988 Sep; 193(6):706-12. PubMed ID: 3192450
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide Reduces Vascular Endothelial Growth Factor Immunostaining in Canine Splenic Hemangiosarcoma.
Bray JP; Munday JS
Vet Sci; 2020 May; 7(2):. PubMed ID: 32443710
[TBL] [Abstract][Full Text] [Related]
19. Surgery and doxorubicin in dogs with hemangiosarcoma.
Ogilvie GK; Powers BE; Mallinckrodt CH; Withrow SJ
J Vet Intern Med; 1996; 10(6):379-84. PubMed ID: 8947871
[TBL] [Abstract][Full Text] [Related]
20. Retrospective evaluation of thrombocytopenia and tumor stage as prognostic indicators in dogs with splenic hemangiosarcoma.
Masyr AR; Rendahl AK; Winter AL; Borgatti A; Modiano JF
J Am Vet Med Assoc; 2021 Mar; 258(6):630-637. PubMed ID: 33683962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
